Covid Vaccine Shortage May Last Months: Johns Hopkins

Covid Vaccine Shortage May Last Months: Johns Hopkins

Assessment

Interactive Video

Business, Social Studies, Engineering, Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The video discusses the need for mass vaccination sites and outreach in the US, challenges in managing public expectations for vaccine rollout, and issues with vaccine supply and distribution. It reports on Merck shutting down its COVID vaccine program due to lackluster data and examines the UK's strategy of vaccinating as many people as possible with the first dose. The importance of balancing immediate actions with long-term confidence in vaccine programs is emphasized.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What are the two main strategies mentioned for increasing vaccination rates in the US?

Mobile vaccination units and drive-through clinics

Online registration and home delivery

Mass vaccination sites and community outreach

International vaccine imports and local production

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What was a significant challenge during the H1N1 vaccine rollout that is also relevant to the current situation?

Lack of public interest

High production costs

Delayed vaccine availability

Excessive vaccine supply

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is one of the main reasons for the current vaccine shortage?

Inefficient distribution channels

Lack of government funding

Excessive demand from non-risk groups

Insufficient manufacturing capacity

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Why did Merck decide to shut down its COVID vaccine program?

High production costs

Lackluster data and immune response

Regulatory issues

Competition from other vaccines

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the UK's strategy for COVID vaccination, and what is the scientific basis for it?

Using a mix of different vaccines to increase coverage

Focusing on high-risk groups only, due to limited supply

Vaccinating as many as possible with the first dose, hoping for some protection

Vaccinating everyone with two doses, based on 95% effectiveness